Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

Astrid Zobel, Thomas Nickel, Heike Künzel et al. · Journal of Psychiatric Research · 2000 · 704 citations

Medicine, Pharmacology, Psychiatry +14

Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression

Juan F. López, Derek Chalmers, Karley Y. Little et al. · Biological Psychiatry · 1998 · 703 citations

Medicine, Neurobiology, Neuroscience +14

Pet imaging of serotonin 1A receptor binding in depression

Wayne C. Drevets, Ellen Frank, Julie C. Price et al. · Biological Psychiatry · 1999 · 674 citations

Medicine, Neuroscience, Psychiatry +16

Past, Present, and Future Directions for Defining Optimal Treatment Outcome in Depression

Martin B. Keller · JAMA · 2003 · 389 citations

Nursing, Neuroscience, Psychiatry +17

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.

Linda S. Brady, Harvey J. Whitfield, Robert J. Fox et al. · Journal of Clinical Investigation · 1991 · 339 citations · Full text

Medicine, Neuroscience, Pharmacology +17